Tech Company Financing Transactions
Inceptor Bio Funding Round
Inceptor Bio secured a $37 million Series A funding round on 5/19/2022. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/19/2022
Transaction Type
Venture Equity
Amount
$37,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the Series A financing will be used to advance Inceptor Bio's CAR-T lead program to a Phase I clinical trial and continue development of its CAR-M and CAR-NK platforms.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2450 Perimeter Park Dr. 200
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Undisclosed
Website
Email Address
Overview
Inceptor Bio is a cell therapy biotechnology company building multiple platforms to address difficult-to-treat cancers. Our platforms are focused on novel mechanisms that drive enhanced immune cell performance in the tumor microenvironment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shailesh Maingi
Browse more venture capital transactions:
Prev: 5/19/2022: Adgile Media Group venture capital transaction
Next: 5/19/2022: Cyscale venture capital transaction
Share this article
News on VC Transactions
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs